Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1997-09-05
2000-12-12
Crouch, Deborah
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 936, 514825, A01N 6300, A61K 4800
Patent
active
061594644
ABSTRACT:
Methods for treating a connective tissue disorder by introducing at least one gene encoding a product into at least one target cell of a mammalian host for use in treating the mammalian host are disclosed. These methods include employing recombinant techniques to produce a vector molecule containing the DNA sequence encoding for the product and infecting the target cell of the mammalian host using the vector. The injection can be done in vivo, by directly injecting the vector into the host, or can be done in vitro by transfecting a population of cultured target cells with the vector and transplanting them each into the host. Nonviral means can also be used to introduce the DNA sequence to the host. Administration of more than one gene of interest results in an enhanced therapeutic benefit. Also disclosed is a method for treating a connective tissue disorder by introducing at least one gene encoding a product into at least one target cell of a joint of a host for use in treating multiple joints of the host. Injection of a vector molecule containing the DNA sequence encoding for a product of interest, or non-viral introduction of such a DNA sequence, to one join of a mammalian host results in a therapeutic benefit in that joint as well as other joints in the host
REFERENCES:
patent: 4396601 (1983-08-01), Salser et al.
patent: 4766069 (1988-08-01), Auron et al.
patent: 4778806 (1988-10-01), Bender et al.
patent: 4780470 (1988-10-01), Bender et al.
patent: 4794114 (1988-12-01), Bender et al.
patent: 4816436 (1989-03-01), Jacobs
patent: 4870101 (1989-09-01), Ku et al.
patent: 4935343 (1990-06-01), Allison et al.
patent: 4968607 (1990-11-01), Dower et al.
patent: 5081228 (1992-01-01), Dower et al.
patent: 5180812 (1993-01-01), Dower et al.
patent: 5792751 (1998-08-01), Ledley et al.
Blau et al. (Nov. 2, 1995) New Eng. J. Med., 1204-1207.
Sawchuk et al. (1996) Human Gene Therapy 7, 499-506.
Zhang et al. (1997) J. Clin. Invest. 100, 1951-1957.
Evans, C. et al., "Pathways to gene therapy in rhumatoid arthritis," Curr Opinion in Rheumatology, 8:230-234 (1996).
Roessler, B.J. et al., "Adenoviral-mediated Gene Transfer to Rabbit Synovium In Vivo," J. Clin. Invest., 92:1085-1092 (1993).
Roessler, B.J. et al., "Inhibition of Interleukin-1-Induced Effects in Synoviocytes Transduced with the Human IL-1 Receptor Antagonist cDNA Using an Adenoviral Vector," Human Gene Therapy, 6:307-316 (1995).
Nicolau et al., "In Vivo Expression of Rat Insulin After Intravenous Administration of the Liposome-Entrapped Gene For Rat Insulin I", Proc. Natl Acad. Sci. USA, vol. 80, pp. 1068-1072 (Feb. 1983).
Aston and Bentley, "Repair of Articular Surfaces by Allografts of Articular and Growth-Plate Cartilage", The Journal of Bone and Joint Surgery, vol. 68 B, No. 1, pp. 29-35 (Jan. 1986).
Pettipher et al., "Interleukin 1 Induces Leukocyte Infiltration and Cartilage Proteoglycan Degradation in the Synovial Joint", Proc. Natl. Acad. Sci. USA, vol. 83, pp. 8749-8753 (Nov. 1986).
Price et al., "Lineage Analysis in the Vertebrate Nervous System By Retrovirus-Mediated Gene Transfer", Proc. Natl. Acad. Sci. USA, vol. 84, pp. 156-160 (Jan. 1987).
Korman et al., "Expression of Human Class II Major Histocompatibility Complex Antigens Using Retrovirus Vectors", Proc. Natl. Acad. Sci. USA, vol. 84, pp. 2150-2154 (Apr. 1987).
Banerjee et al., "Immunosuppression of Collagen-Induced Arthritis in Mice with an Anti-IL-2 Receptor Antibody", The Journal of Immunology, vol. 141, No. 4, pp. 1150-1154 (Aug. 1988).
Danos et al., "Safe and Efficient Generation of Recombinant Retroviruses with Amphotropic and Ecotropic Host Ranges", Proc. Natl. Acad. Sci. USA, vol. 85, pp. 6460-6464 (Sep. 1988).
Rosenberg et al., "Grafting Genetically Modified Cells to the Damaged Brain: Restorative Effects of NGF Expression", Science, vol. 242, pp. 1575-1578 (Dec. 1988).
Grande et al., "The Repair of Experimentally Produced Defects in Rabbit Articular Cartilage by Autologous Chondrocyte Transplantation", Journal of Orthopaedic Research, vol. 7, No. 2, pp. 208-218 (1989).
Wakitani et al., "Repair of Rabbit Articular Surfaces with Allograft Chondrocytes Embedded in Collagen Gel", The Journal of Bone and Joint Surgery, vol. 71-B, No. 1, pp. 74-80 (Jan. 1989).
Chin et al., "Interleukin 1 Receptors on Rabbit Articular Chondrocytes: Relationship Between Biological Activity and Receptor Binding Kinetics", The FASEB Journal, vol. 4, pp. 1481-1487 (Mar. 1990).
Fanslow et al., "Regulation of Alloreactivity in Vivo by a Soluble Form of the Interleukin-1 Receptor", Science, vol. 248, pp. 739-742 (May 1990).
Gao et al., "A Novel Cationic Liposome Reagent for Efficient Transfection of Mammalian Cells", Biochemical and Biophysical Research Communications, vol. 179, No. 1, pp. 280-285 (Aug. 1991).
Bandara et al., "Intraarticular Expression of IRAP by Gene Transfer", Arthritis Rheum., vol. 39 (supp), S193, C161 (1992).
Evans, "Transferring Therapeutic Genes to Joints: A Pittsburgh Idea", The Pittsburgh Orthopaedic Journal, vol. 3, pp. 130-131 (1992).
Evans et al., "Gene Transfer to Joints for Arthritis Therapy", J. Cell Biochem., 16F:V207 (1992).
Bandara et al., "Gene Transfer to Synoviocytes: Prospects for Gene Treatment of Arthritis", DNA and Cell Biology, vol. 11, No. 3, pp. 227-231 (1992).
Evans et al., "Synovial Cell Transplants for Gene Transfer to Joints", Transplantation Proceedings, vol. 24, No. 6, p. 2966 (Dec. 1992).
Bandara et al., "Gene Transfer to Synovium", Trans. Orthop. Res. Soc., 18, p. 242 (1993).
Wooley et al, "The Effect of an Interleukin-1 Receptor Antagonist Protein on Type II Collagen-Induced Arthritis and Antigen-Induced Arthritis in Mice", Arthritis & Rheumatism, vol. 36, pp. 1305-1314 (1993).
Bandara et al., "Intraarticular Expression of Biologically Active Interleukin 1-Receptor-Antagonist Protein By Ex Vivo Gene Transfer", Proc. Natl. Acad. Sci. USA vol. 90, pp. 10764-10768 (Nov. 1993).
Endo et al., "Experimental Arthritis Induced by Continuous Infusion of IL-8 Into Rabbit Knee Joints", Clinical & Experimental Immunology, vol. 96, pp. 31-35 (1994).
Evans Christopher H.
Ghivizzani Steven C.
Glorioso Joseph C.
Robbins Paul D.
Crouch Deborah
University of Pittsburgh of the Commonwealth System of Higher Ed
LandOfFree
Viral vectors to inhibit leukocyte infiltration or cartilage deg does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral vectors to inhibit leukocyte infiltration or cartilage deg, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral vectors to inhibit leukocyte infiltration or cartilage deg will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-213507